How Does Parkinson’s Prevalence Differ in Populations With Pesticide Exposure, What Percentage Are Affected, and How Do Their Risks Compare With Unexposed Groups? 🌾🧠

This article is written by mr.hotsia, a long term traveler and storyteller who runs a YouTube travel channel followed by over a million followers. Over the years he has crossed borders and backroads throughout Thailand, Laos, Vietnam, Cambodia, Myanmar, India and many other Asian countries, sleeping in small guesthouses, village homes and roadside inns. Along the way he has listened to real life health stories from locals, watched how people actually live day to day, and collected simple lifestyle ideas that may help support better wellbeing in practical, realistic ways.

In farming villages and market towns, people often talk about pesticides as if they are only part of the field, the pump, the crop, the weeds, or the insects. But over the years, scientists have kept returning to a harder question: when pesticide exposure becomes part of human life for long enough, does it also become part of Parkinson’s disease risk?

The broad answer is yes, the evidence generally points toward higher Parkinson’s risk in people exposed to pesticides, especially occupationally exposed groups, but the exact size of that risk varies by study design, pesticide type, exposure method, and how Parkinson’s was diagnosed. What the research does not give us very cleanly is one universal absolute percentage of exposed people who develop Parkinson’s. Most studies report relative risk, odds ratios, or hazard ratios, not one neat “x% of exposed people get Parkinson’s” number. That is important, because it keeps us honest. The clearest message from recent reviews is that pesticide exposure is associated with increased Parkinson’s occurrence, while the exact absolute percentage affected depends heavily on population, age, and exposure context.

Why this question is harder than it sounds

At first glance, it seems simple. Compare people exposed to pesticides with people who were not exposed, then calculate the percentage with Parkinson’s. But real-world research is messier than a clean field after harvest.

Some studies look at occupational exposure in farmers, pesticide applicators, or rural workers. Some look at household pesticide use. Some examine specific compounds such as organochlorines, paraquat, maneb, or herbicides. Some measure exposure through blood samples, while others rely on questionnaires or job history. Some studies measure incidence, meaning new cases over time. Others measure prevalence, meaning how many people already have Parkinson’s at a point in time.

That means there is no single global percentage for “pesticide-exposed populations.” Still, the overall pattern is consistent enough to matter clinically and publicly. Occupational and environmental pesticide exposure is repeatedly associated with higher Parkinson’s risk than no exposure.

What percentage are affected in exposed populations?

This is the point where the most careful answer is better than the most dramatic one.

Most major pesticide-Parkinson’s studies do not report one universal absolute prevalence percentage among exposed versus unexposed groups. Instead, they tell us how much the risk rises. So the best way to answer your question is with examples from real cohorts and then explain the relative-risk pattern.

One useful example comes from the Agricultural Health Study, a large U.S. cohort of farmers, pesticide applicators, and spouses. In one long follow-up analysis, there were 491 incident Parkinson’s cases among 66,110 participants, which is roughly 0.74% over the follow-up period in that agricultural cohort overall. But that paper did not reduce the story to one simple exposed-versus-unexposed absolute percentage for all pesticides combined. Instead, it reported associations for specific pesticides and exposure patterns.

Another example comes from a Brazilian review, where one included study reported that household pesticide exposure for more than 30 days per year at any time during life implied about two times more risk of developing Parkinson’s. Again, the key result was the relative increase in risk, not one universal absolute prevalence percentage.

So the fairest summary is this: absolute percentages vary widely and are rarely reported in a single comparable way, but in agricultural or pesticide-exposed groups, Parkinson’s occurrence is generally higher than in unexposed groups, and the increase is usually described in relative terms rather than as one fixed percentage.

How much higher is the risk compared with unexposed groups?

This is where the literature is strongest.

An older but still widely cited meta-analysis found that all pesticide exposure was associated with an odds ratio of 1.62, meaning about a 62% higher odds of Parkinson’s disease compared with unexposed groups. In the same summary, herbicides had an odds ratio of 1.40, insecticides 1.50, and occupational exposure 2.50, which suggests particularly elevated risk when pesticide exposure is tied directly to work.

A 2024 systematic review and meta-analysis focused specifically on organochlorine pesticides found elevated Parkinson’s risk as well. When exposure was assessed through blood samples, the odds ratio was 1.54. For indirect exposure assessment, the odds ratio was 1.19. Insecticidal organochlorines were also significantly associated with Parkinson’s risk.

A 2025 review discussing the causal relationship literature summarized several older case-control studies in the same direction, including:

• professional pesticide use associated with Parkinson’s at about OR 1.8

• herbicide exposure in one Detroit-area study at about OR 4.1

• insecticide exposure in the same study at about OR 3.55

• herbicide or pesticide use in one Taiwan study at about OR 2.89

• paraquat in that study at about OR 3.22.

These are not all the same kind of exposure, and they should not be mashed into one single average number. But together they paint a very clear picture: exposed groups usually have higher Parkinson’s risk than unexposed groups, and in some occupational or chemical-specific settings the increase is substantial.

Does the type of pesticide matter?

Yes, very likely.

The literature does not suggest that all pesticides behave identically. Some of the strongest concern has centered on insecticides, herbicides, and certain historically important chemicals such as organochlorines, paraquat, and maneb. The 2024 organochlorine review showed a clear signal for organochlorine exposure, especially in biologically measured studies. Older meta-analytic work also found positive associations for herbicides and insecticides, while fungicides were less consistently associated.

The Agricultural Health Study also supports the idea that specific pesticides matter more than broad pesticide use as a vague category. Its authors reported evidence of increased Parkinson’s risk for some pesticides rather than all pesticides equally, and emphasized the need to study current and newer pesticides with better exposure assessment.

So when people ask whether “pesticides” increase Parkinson’s risk, the scientifically precise answer is that some pesticides and some exposure contexts appear more strongly associated than others.

Why might pesticide exposure increase Parkinson’s risk?

The biological story is plausible enough that the epidemiology has not been left standing alone.

Many pesticides have been linked in experimental work to oxidative stress, mitochondrial dysfunction, dopaminergic neuronal injury, and neuroinflammation, all of which are relevant to Parkinson’s disease biology. The 2024 Frontiers paper on household pesticide exposure also noted that many household pesticide substances can cause oxidative damage and mitochondrial dysfunction, and some have been shown to injure the nigrostriatal dopaminergic system in animal models.

The Brazilian systematic review also highlights that pesticide exposure may interact with genetic susceptibilities, including variants in PINK1 and detoxification-related genes such as GSTM1, GSTT1, and GSTP1, potentially lowering age at onset or amplifying risk. That suggests the story is not just toxin alone or gene alone. It may often be toxin meeting vulnerability.

Are all exposed people equally vulnerable?

No.

Several studies and reviews suggest susceptibility differs by sex, occupation, head injury history, protective equipment use, genetic background, and probably by total cumulative dose and duration. In the Agricultural Health Study, the authors noted higher susceptibility for pesticide-associated Parkinson’s among some individuals with head injury and suggested a protective influence from chemical-resistant glove use, though they also called for more research.

The Brazilian review similarly found that associations were often stronger in men, in rural or non-urban settings, and in people with certain gene variants.

This matters because it means pesticide exposure is not a simple switch where everyone flips from safe to unsafe at the same threshold. Risk seems to behave more like a field fire: the chemical is the spark, but dryness, wind, terrain, and nearby fuel all influence how far it runs.

Do exposed populations have a much higher prevalence, or are they just diagnosed more often?

The evidence leans toward real increased risk, not just more diagnosis.

Many of the pesticide studies involve farming or occupational groups who might actually have less specialist access in some settings, not more. That weakens the idea that the association is merely because exposed populations are examined more closely. The organochlorine meta-analysis, case-control studies, and the Agricultural Health Study all point in the same direction despite using different exposure methods.

Still, as with all observational epidemiology, caution is necessary. Exposure measurement is often imperfect. Self-report can be biased. Workers may be exposed to mixtures, not single compounds. Some studies are retrospective. So the best wording is that pesticide exposure is associated with increased Parkinson’s risk, and the causal case is getting stronger, but not every detail is fully settled.

What should people take from this in real life?

The first takeaway is not panic. It is realism.

A person with pesticide exposure does not automatically develop Parkinson’s. Most exposed people still do not. But compared with unexposed groups, their odds are often higher, sometimes modestly, sometimes substantially depending on the exposure type and intensity.

The second takeaway is that occupational protection matters. The Agricultural Health Study’s discussion of protective glove use is a reminder that exposure is not a binary all-or-none story. The dose and route likely matter.

The third takeaway is that public health policy matters. The Brazilian review explicitly called for stronger public policy because the evidence linking pesticide exposure and Parkinson’s occurrence was strong enough to justify concern.

The fourth takeaway is that genetics may amplify the effect in some people. So for some workers, residents, or families, the same exposure may not land with the same biological force.

The bottom line

Parkinson’s appears to be more common in pesticide-exposed populations than in unexposed groups, but the literature usually reports this as higher risk rather than one universal absolute percentage. In large agricultural cohorts, the overall observed burden can be on the order of less than 1% over long follow-up, but the key message is the relative increase in risk rather than one fixed prevalence figure.

Across major reviews, pesticide exposure is associated with roughly:

• OR 1.62 for all pesticide exposure overall

• OR 1.40 for herbicides

• OR 1.50 for insecticides

• OR 2.50 for occupational exposure in one meta-analytic summary

• OR 1.54 for blood-measured organochlorine exposure

• and higher associations for some specific compounds in certain studies.

So the simplest answer is this: pesticide exposure does not guarantee Parkinson’s, but it does appear to tilt the odds in the wrong direction, especially with occupational or long-term exposure. The exposed field is not the same field as the unexposed one.

FAQs

1. Does pesticide exposure increase Parkinson’s risk?

Yes. Multiple reviews and meta-analyses show that pesticide exposure is associated with increased Parkinson’s risk.

2. What percentage of exposed people get Parkinson’s?

There is no single universal percentage. Most studies report relative risk rather than one fixed absolute percentage for all exposed populations.

3. What is one real-world percentage example?

In the Agricultural Health Study, there were 491 incident Parkinson’s cases among 66,110 participants overall, about 0.74% over follow-up, but the study mainly reported risk associations rather than one universal exposed-versus-unexposed percentage.

4. How much higher is the risk compared with unexposed groups?

A widely cited meta-analysis found an overall odds ratio of 1.62, meaning about 62% higher odds in exposed groups.

5. Are occupationally exposed people at higher risk?

Yes, often more clearly so. One meta-analytic summary reported OR 2.50 for occupational exposure.

6. Do all pesticides carry the same risk?

No. Herbicides, insecticides, organochlorines, paraquat, and maneb have all attracted attention, but the strength of association differs by chemical and study.

7. Is the evidence stronger for organochlorines?

There is a significant signal. A 2024 meta-analysis found blood-assessed organochlorine exposure associated with Parkinson’s at OR 1.54.

8. Do genes matter too?

Yes. Some studies suggest pesticide effects may be amplified by gene variants such as PINK1 and detoxification-related GST genes.

9. Can protective equipment reduce risk?

Possibly. The Agricultural Health Study suggested that chemical-resistant glove use may be protective, though more research is needed.

10. What is the simplest way to think about pesticides and Parkinson’s?

Pesticides are not destiny, but repeated exposure appears to push the odds upward, especially in occupational settings and with certain chemicals.

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. Learn more